NYSE:SRE • US8168511090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SEMPRA (SRE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-06 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-04 | Argus Research | Upgrade | Hold -> Buy |
| 2026-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-03 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-22 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-22 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-24 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-28 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-10-22 | Jefferies | Maintains | Hold -> Hold |
| 2025-10-20 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-09-24 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-26 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.72B 15.80% | 13.185B -21.14% | 13.702B 3.92% | 14.612B 6.64% | 14.03B -3.98% | 14.075B 0.32% | 15.338B 8.97% | 13.715B -10.58% | |
| EBITDA YoY % growth | 5.942B 29.85% | 5.399B -9.14% | 5.643B 4.52% | 6.327B 12.12% | 6.219B -1.71% | 6.669B 7.24% | 7.301B 9.48% | 7.554B 3.47% | |
| EBIT YoY % growth | 3.715B 45.29% | 2.962B -20.27% | 3.08B 3.98% | 3.63B 17.86% | 3.625B -0.14% | 3.781B 4.30% | 3.771B -0.26% | 3.646B -3.31% | |
| Operating Margin | 22.22% | 22.46% | 22.48% | 24.84% | 25.84% | 26.86% | 24.59% | 26.58% | |
| EPS YoY % growth | 4.61 0.11% | 4.62 0.22% | 4.72 2.16% | 5.15 9.09% | 5.58 8.42% | 6.03 8.01% | 6.63 9.99% | 7.22 8.88% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.52 5.38% | 1.01 13.51% | 1.12 1.27% | 1.59 23.97% | 1.64 7.92% | 1.07 6.21% | 1.22 8.54% | 1.56 -1.43% | 1.77 8.37% | 1.19 10.79% | 1.42 16.64% |
| Revenue Q2Q % growth | 4.213B 10.81% | 3.055B 1.83% | 3.316B 5.24% | 4.641B 23.79% | 4.351B 3.28% | 2.851B -6.68% | 3.076B -7.24% | 4.726B 1.83% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 1.821B 13.88% | 1.454B -22.54% | 1.448B -40.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.065B 11.05% | 661.86M 13.33% | 718.32M 44.53% | 1.187B 14.13% | 1.146B 7.61% | 751.01M 13.47% | 810.3M 12.80% | 1.245B 4.89% | N/A | N/A | N/A |
All data in USD
23 analysts have analysed SRE and the average price target is 102.08 USD. This implies a price increase of 9.8% is expected in the next year compared to the current price of 92.965.
SEMPRA (SRE) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of SEMPRA (SRE) is 1.52 USD and the consensus revenue estimate is 4.21B USD.
The consensus rating for SEMPRA (SRE) is 78.2609 / 100 . This indicates that analysts generally have a positive outlook on the stock.